Automated Call vs Text Messaging: Percentage of Tested Patients
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
Measures 6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note | Source |
|---|---|---|---|---|---|---|
| Risk in group 1 | 0.00267 | 0.00153 | 0.00467 | wilson | ClinicalTrials.gov | |
| Risk in group 2 | 0.0054 | 0.00366 | 0.00796 | wilson | ClinicalTrials.gov | |
| Risk difference, group 1 minus group 2 | -0.00273 | -0.00553 | -0.0000796 | newcombe hybrid score | ClinicalTrials.gov | |
| Risk ratio, group 1 over group 2 | 0.495 | 0.249 | 0.984 | log | ClinicalTrials.gov | |
| Odds ratio, group 1 over group 2 | 0.494 | 0.248 | 0.984 | log | ClinicalTrials.gov | |
| Number needed to treat, for one fewer participant with the outcome on Automated Call than on Text Messaging | 367 | 181 | 12,600 | from the risk difference interval | ClinicalTrials.gov |
Groups 2
Neither group, or both, names a comparator, so the groups keep ClinicalTrials.gov's order.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code | Source |
|---|---|---|---|---|---|---|
| Group 1 | Automated Call | Patients receive up to two automated phone calls in English or Spanish depending the patients' language indicated in their electronic health record (EHR), between the hours of 10:00am and 9:00pm Monday through Friday.~Community outreach method: The method includes automated call and text messaging to increase testing for COVID-19 | 12 | 4,489 | OG000 | ClinicalTrials.gov |
| Group 2 | Text Messaging | Patients receive up to two text messages in English or Spanish depending the patients' language indicated in their electronic health record (EHR), between the hours of 10:00am and 9:00pm Monday through Friday.~Community outreach method: The method includes automated call and text messaging to increase testing for COVID-19 | 25 | 4,631 | OG001 | ClinicalTrials.gov |
Outcome 5
| Field | Value | Source |
|---|---|---|
| Type | PRIMARY | ClinicalTrials.gov |
| Title | Percentage of Tested Patients | ClinicalTrials.gov |
| Description | The percentage of patients who undergo testing within one month of initial contact (automated call vs text messaging) and by the end of the study period (to consider individuals who could not come to the clinic within one month) | ClinicalTrials.gov |
| Time frame | 1 month | ClinicalTrials.gov |
| Population | Because of extremely low testing uptake, slow accrual at participating health centers and continuously changing COVID pandemic, our team was forced to terminate the intervention study and pivot to alternate strategies. Because the study was terminated, the data of the percentage of patients who undergo testing by the end of the study period (automated call vs text messaging) was not collected. | ClinicalTrials.gov |
Trial 8
| Field | Value | Source |
|---|---|---|
| Title | COVID-19 Testing in Underserved and Vulnerable Populations | ClinicalTrials.gov |
| NCT number | NCT05315908 | ClinicalTrials.gov |
| Phases | NA | ClinicalTrials.gov |
| Conditions | Heart Failure, Coronary Artery Disease, Cancer, Chronic Kidney Diseases, COPD, Obesity, Sickle Cell Disease, Diabetes Mellitus, Type 2 | ClinicalTrials.gov |
| Interventions | Community outreach method | ClinicalTrials.gov |
| Lead sponsor | Jesse Nodora | ClinicalTrials.gov |
| Results first posted | 2024-02-28 | ClinicalTrials.gov |
| Results on ClinicalTrials.gov | https://clinicaltrials.gov/study/NCT05315908?tab=results | ClinicalTrials.gov |
Source 4
| Field | Value | Source |
|---|---|---|
| Release | trial-comparisons-2026-03-23-0.1.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57 | ClinicalTrials.gov |
| AACT copy | 2026-03-23 | ClinicalTrials.gov |
| Tables read | outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet | ClinicalTrials.gov |
Release trial-comparisons-2026-03-23-0.1.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.